Assignee

SERMONIX PHARMACEUTICALS INC

US2 patents

Top patents by PatentIndex Score

US12023321B2Jul 2, 2024

Lasofoxifene treatment of aromatase-resistant ER+cancer

SERMONIX PHARMACEUTICALS INC2 citations67

US12433866B2Oct 7, 2025

Lasofoxifene treatment of aromatase-resistant ER+ cancer

SERMONIX PHARMACEUTICALS INC0 citations56